About Index Trending news
Lists
Pricing
Cellartis

Cellartis

Cellartis

Cellartis develops human embryonic stem cells and technology for drug discovery research, toxicity testing and regenerative medicine.

Elsewhere

Alexa global traffic share

Twitter followers

13 Dec 2005
$9,540,000
Venture capital